- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- August 2024
- 176 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- May 2024
- 166 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- October 2024
- 123 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- May 2024
- 182 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- May 2024
- 185 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- May 2024
- 186 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- March 2025
- 182 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2025
- 182 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2025
- 182 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- January 2025
- 182 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- November 2024
- 180 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- May 2024
- 182 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- May 2024
- 185 Pages
Global
From €4095EUR$4,500USD£3,511GBP

The Transplantation market within the context of Biotechnology is focused on the development of treatments and technologies that enable the successful transfer of organs, tissues, and cells from one individual to another. This includes the development of new methods for organ preservation, the development of new immunosuppressive drugs, and the development of new technologies for organ matching. Additionally, the market is focused on the development of new methods for organ harvesting, as well as the development of new methods for organ transplantation.
The Transplantation market is a rapidly growing sector of the biotechnology industry, with many companies investing in research and development to improve the success rate of organ transplants. Companies in this market include Organogenesis, Organovo, Histogenics, and United Therapeutics. Additionally, many pharmaceutical companies are investing in the development of new immunosuppressive drugs to improve the success rate of organ transplants. Show Less Read more